
Albireo Pharma ALBO
Quartalsbericht 2022-Q3
hinzugefügt 08.11.2022
Albireo Pharma P/CF 2011-2026 | ALBO
P/CF Jährlich Albireo Pharma
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| -5 | -6.92 | -5.07 | -10.6 | -10 | -3.16 | -0.834 | -1.74 | -2.12 | -1.83 | -1.39 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -0.834 | -10.6 | -4.42 |
P/CF anderer Aktien in der Pharmaeinzelhändler
| Name | P/CF | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
-0.654 | - | 2.43 % | $ 254 M | ||
|
I-Mab
IMAB
|
-0.266 | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
11.6 | - | - | $ 40.3 B | ||
|
Apellis Pharmaceuticals
APLS
|
61.2 | $ 20.29 | -1.98 % | $ 2.56 B | ||
|
Aptorum Group Limited
APM
|
-3.44 | $ 0.8 | -5.3 % | $ 4.36 M | ||
|
Biophytis SA
BPTS
|
-23.1 | - | -13.47 % | $ 169 M | ||
|
Axsome Therapeutics
AXSM
|
-92.9 | $ 166.0 | -0.23 % | $ 8.26 B | ||
|
AbCellera Biologics
ABCL
|
-7.33 | $ 3.74 | -2.23 % | $ 1.12 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.88 | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
-13.2 | - | -18.52 % | $ 27.3 M | ||
|
Burford Capital Limited
BUR
|
11.6 | $ 8.59 | -1.66 % | $ 1.4 B | ||
|
Certara
CERT
|
11.2 | $ 7.22 | 2.34 % | $ 1.16 B | ||
|
Catalyst Pharmaceuticals
CPRX
|
14.6 | $ 23.78 | -0.42 % | $ 2.91 B | ||
|
Corvus Pharmaceuticals
CRVS
|
-3.93 | $ 18.17 | 1.57 % | $ 873 M | ||
|
Adverum Biotechnologies
ADVM
|
-0.826 | - | - | $ 86.2 M | ||
|
Институт стволовых клеток человека
ISKJ
|
-89 | - | - | - | ||
|
ARCA biopharma
ABIO
|
-8.36 | - | 1052.0 % | $ 415 M | ||
|
Eton Pharmaceuticals
ETON
|
16.8 | $ 17.9 | -1.38 % | $ 459 M | ||
|
Exelixis
EXEL
|
13.2 | $ 40.5 | -1.29 % | $ 11 B | ||
|
Acer Therapeutics
ACER
|
-0.401 | - | 2.71 % | $ 14 M | ||
|
Alpine Immune Sciences
ALPN
|
-6.14 | - | - | $ 2.17 B | ||
|
Acorda Therapeutics
ACOR
|
-1.2 | - | -24.86 % | $ 820 K | ||
|
Galectin Therapeutics
GALT
|
-1.82 | $ 2.89 | -5.56 % | $ 180 M | ||
|
Capricor Therapeutics
CAPR
|
-6.07 | $ 26.3 | -2.08 % | $ 704 M | ||
|
Acasti Pharma
ACST
|
-2.73 | - | 4.01 % | $ 150 M | ||
|
Codexis
CDXS
|
-5.9 | $ 1.02 | -0.33 % | $ 74.9 M | ||
|
Galapagos NV
GLPG
|
-8.78 | $ 33.13 | -2.82 % | $ 2.69 B | ||
|
Greenwich LifeSciences
GLSI
|
-15.8 | $ 27.88 | 1.79 % | $ 363 M | ||
|
Galecto
GLTO
|
-0.634 | $ 29.63 | -1.41 % | $ 787 M | ||
|
Genmab A/S
GMAB
|
4.08 | $ 27.66 | -6.71 % | $ 17.7 B | ||
|
Halozyme Therapeutics
HALO
|
14.8 | $ 68.58 | -1.82 % | $ 8.22 B | ||
|
CureVac N.V.
CVAC
|
-4.82 | - | - | $ 867 M | ||
|
Aeterna Zentaris
AEZS
|
-4.82 | - | 5.93 % | $ 314 M | ||
|
Hoth Therapeutics
HOTH
|
-0.941 | $ 1.0 | -1.47 % | $ 6.38 M | ||
|
AgeX Therapeutics
AGE
|
-0.0018 | - | -10.17 % | $ 12.2 K | ||
|
Harmony Biosciences Holdings
HRMY
|
4.62 | $ 28.32 | -2.01 % | $ 1.63 B | ||
|
Aeglea BioTherapeutics
AGLE
|
-4.6 | - | - | $ 1.01 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-0.64 | - | - | $ 26.5 M | ||
|
ImmuCell Corporation
ICCC
|
114 | $ 6.3 | -3.67 % | $ 51.5 M | ||
|
AIkido Pharma
AIKI
|
-1.3 | - | 1.93 % | $ 17.4 M | ||
|
Agenus
AGEN
|
-0.000958 | $ 3.27 | -2.1 % | $ 1.17 M | ||
|
Ayala Pharmaceuticals
AYLA
|
-0.224 | - | - | $ 7.46 M | ||
|
Akero Therapeutics
AKRO
|
-14.1 | - | - | $ 3.67 B | ||
|
Agios Pharmaceuticals
AGIO
|
-4.37 | $ 28.57 | -2.16 % | $ 1.66 B | ||
|
Immuron Limited
IMRN
|
-274 | $ 0.75 | -0.69 % | $ 6.46 M | ||
|
Immatics N.V.
IMTX
|
-6.15 | $ 10.09 | 1.0 % | $ 635 M | ||
|
Immunic
IMUX
|
-1.69 | $ 1.13 | 6.61 % | $ 176 M | ||
|
Immunovant
IMVT
|
-6 | $ 27.09 | -2.38 % | $ 4.11 B | ||
|
Inhibrx
INBX
|
-9.03 | $ 76.39 | -1.42 % | $ 3.6 B | ||
|
InMed Pharmaceuticals
INM
|
-0.235 | $ 0.8 | -2.44 % | $ 1.96 M |